Amyotrophic lateral sclerosis
On this page:
The Ottawa Hospital is conducting cutting-edge research to improve our understanding of amyotrophic lateral sclerosis (ALS) and develop better treatments. This page includes selected news stories about our ALS research, links to researchers working in this area and related resources. Learn more below.
Research & News
Labs and Groups
These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team.
Kothary Lab
Sachs Lab
Matti Allen
Clinician Investigator, Neuroscience
Publications
The following research publications from The Ottawa Hospital are pulled from PubMed, with publication date of 2020 or later. Note that PubMed is hosted by the U.S. National Library of Medicine and is only available in English.
Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the US.
2026-01-01 Go to publicationVariability across versions of the self-administered ALSFRS-R: a review and call for harmonization.
2025-11-01 Go to publicationSedating with volatile anaesthetics for COVID-19 and non-COVID-19 acute hypoxaemic respiratory failure patients in ICU (SAVE-ICU): protocol for a randomised clinical trial.
2025-10-13 Go to publicationAtypical features including acquired oculomotor apraxia in C9orf72-associated familial primary lateral sclerosis.
2025-09-26 Go to publicationResources
Neuroscience Program at the Ottawa Hospital Research Institute
Search for clinical trials at The Ottawa Hospital related to this disease or condition.